Platelet-associated IgM elevated in patients with chronic hepatitis C contains no anti-platelet autoantibodies.

We investigated whether thrombocytopenia in patients with chronic hepatitis C is due to anti-platelet autoantibodies. Platelet-associated IgG (PAIgG) and platelet-associated IgM (PAIgM) were measured by direct immunofluorescent flow cytometric analysis. Elevation of PAIgM level was detected in 70% of chronic hepatitis C patients, while only a mild elevation of PAIgG level was detected in 32% of the cases. The elevation of PAIgM values in these patients was comparable to that in patients with chronic immune thrombocytopenic purpura (ITP). However, elevated PAIgM was also found in both patients with and without thrombocytopenia, and no correlation was found between PAIgM and platelet count. Eluted PAIgM did not react with normal platelets in all cases with a positive PAIgM value, indicating that eluted PAIgM contained no detectable anti-platelet antibodies. During alpha-interferon therapy, the level of PAIgM increased in association with the decrease in platelet counts in 75% of the cases; however, eluted PAIgM at any day point never reacted with platelets from normal donors. PAIgM was elevated in patients with chronic hepatitis C, but contained no detectable anti-platelet autoantibodies. Thrombocytopenia in these patients is not due to anti-platelet autoantibodies.

[1]  J. Pawlotsky,et al.  Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study , 1994, Hepatology.

[2]  D. Sansonno,et al.  Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection , 1996, European journal of clinical investigation.

[3]  E. Tanaka,et al.  Serum Thrombopoietin (c-MpI Ligand) Levels in Patients with Liver Cirrhosis , 1996, Thrombosis and Haemostasis.

[4]  S. B. Wilson,et al.  Platelet antibodies of the IgM class in immune thrombocytopenic purpura. , 1985, The Journal of clinical investigation.

[5]  Y. Matsuzawa,et al.  High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. , 1994, Thrombosis and haemostasis.

[6]  M. Mori,et al.  Thrombocytopenia associated with hepatitis C viral infection. , 1996, Journal of hepatology.

[7]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[8]  J. George,et al.  Chronic idiopathic thrombocytopenic purpura. , 1994, The New England journal of medicine.

[9]  T. Koga,et al.  Correlation between sectional area of the spleen by ultrasonic tomography and actual volume of the removed spleen , 1979, Journal of clinical ultrasound : JCU.

[10]  K. Kaushansky.  Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.

[11]  Y. Tomiyama,et al.  Elevated platelet‐associated IgG in SLE patients due to anti‐platelet autoantibody: differentiation between autoantibodies and immune complexes by ether elution , 1993, British journal of haematology.

[12]  F. Lunel.  Hepatitis C virus and autoimmunity: fortuitous association or reality? , 1994, Gastroenterology.

[13]  M. Mizokami,et al.  Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. , 1994, Gastroenterology.

[14]  E. Tanaka,et al.  Type C chronic hepatitis associated with thrombocytopenia in two patients , 1994, Journal of gastroenterology and hepatology.

[15]  G. Everson,et al.  Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. , 1995, The American journal of gastroenterology.

[16]  N. Hayashi,et al.  Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. , 1993, Gastroenterology.

[17]  K. Stevens,et al.  Platelet-bound IgM in autoimmune thrombocytopenia. , 1983, Blood.

[18]  Y. Matsuzawa,et al.  Platelet-Associated Anti-Glycoprotein (GP) IIb-IIIa Autoantibodies in Chronic Immune Thrombocytopenic Purpura Mainly Recognize Cation-Dependent Conformations: Comparison with the Epitopes of Serum Autoantibodies , 1996, Thrombosis and Haemostasis.

[19]  J. Hoofnagle,et al.  Side Effects of Alpha Interferon , 1989, Seminars in liver disease.

[20]  P. Toghill,et al.  Platelet dynamics in chronic liver disease with special reference to the role of the spleen. , 1977, Journal of clinical pathology.

[21]  R. Aster.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.

[22]  G. Kaplanski,et al.  Thrombocytopenic purpura and hepatitis C virus infection. , 1993, Haematologica.

[23]  S. Honda,et al.  Demonstration of platelet antigens that bind platelet‐associated autoantibodies in chronic ITP by direct immunoprecipitation procedure , 1990, British journal of haematology.

[24]  Y. Tomiyama,et al.  Cyclic thrombocytopenia associated with IgM anti‐GPIIb‐IIIa autoantibodies , 1994, British journal of haematology.

[25]  F. Sáez‐royuela,et al.  Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C. , 1992, The American journal of gastroenterology.

[26]  P. Johnson,et al.  Meeting report: International autoimmune hepatitis group , 1993, Hepatology.